Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
70.13
-3.47 (-4.71%)
At close: Apr 28, 2026, 4:00 PM EDT
70.13
0.00 (0.00%)
Pre-market: Apr 29, 2026, 7:35 AM EDT
Arrowhead Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 9,820 | 4,769 | 2,408 | 2,880 | 3,498 | 6,509 | |
| Market Cap Growth | 560.55% | 98.03% | -16.40% | -17.67% | -46.25% | 47.77% | |
| Enterprise Value | 9,604 | 4,588 | 2,436 | 2,799 | 3,183 | 6,017 | |
| Last Close Price | 70.13 | 34.49 | 19.37 | 26.87 | 33.05 | 62.43 | |
| PS Ratio | 9.00 | 5.75 | 678.12 | 11.96 | 14.38 | 47.07 | |
| PB Ratio | 16.95 | 9.47 | 12.60 | 10.03 | 8.36 | 15.92 | |
| P/TBV Ratio | 17.47 | 10.39 | 13.61 | 11.03 | 9.05 | 16.47 | |
| P/FCF Ratio | 30.50 | 30.40 | - | - | - | 44.06 | |
| P/OCF Ratio | 28.94 | 26.56 | - | - | - | 37.99 | |
| EV/Sales Ratio | 8.80 | 5.53 | 686.02 | 11.63 | 13.09 | 43.51 | |
| EV/EBITDA Ratio | 29.49 | 37.52 | - | - | - | - | |
| EV/EBIT Ratio | 31.95 | 46.65 | - | - | - | - | |
| EV/FCF Ratio | 29.83 | 29.25 | - | - | - | 40.72 | |
| Debt / Equity Ratio | 1.24 | 1.48 | 4.46 | 1.34 | 0.20 | 0.06 | |
| Debt / EBITDA Ratio | 2.04 | 5.36 | - | - | - | - | |
| Debt / FCF Ratio | 2.17 | 4.74 | - | - | - | 0.17 | |
| Net Debt / Equity Ratio | -0.38 | -0.34 | 0.91 | -0.04 | -0.69 | -0.84 | |
| Net Debt / EBITDA Ratio | -0.66 | -1.42 | -0.30 | 0.06 | 1.71 | 2.43 | |
| Net Debt / FCF Ratio | -0.67 | -1.11 | -0.29 | 0.04 | 1.52 | -2.32 | |
| Asset Turnover | 0.83 | 0.66 | 0.00 | 0.33 | 0.35 | 0.22 | |
| Quick Ratio | 3.26 | 4.73 | 6.57 | 3.75 | 2.67 | 2.58 | |
| Current Ratio | 3.38 | 4.86 | 6.74 | 3.95 | 2.92 | 2.63 | |
| Return on Equity (ROE) | 75.50% | 8.67% | -254.98% | -59.33% | -42.68% | -32.36% | |
| Return on Assets (ROA) | 14.35% | 4.87% | -39.43% | -17.58% | -15.91% | -15.11% | |
| Return on Invested Capital (ROIC) | 81.47% | 16.53% | -187.71% | -101.05% | -180.86% | -127.38% | |
| Return on Capital Employed (ROCE) | 23.90% | 8.30% | -58.00% | -31.10% | -32.30% | -26.40% | |
| Earnings Yield | 2.06% | -0.03% | -24.90% | -7.13% | -5.03% | -2.16% | |
| FCF Yield | 3.28% | 3.29% | -25.10% | -11.48% | -5.40% | 2.27% | |
| Buyback Yield / Dilution | -10.94% | -11.67% | -12.21% | -1.26% | -1.62% | -3.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.